Jane Street’s Applied Therapeutics APLT Stock Holding History

Jane Street’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,087,404	Closed	-$209K	–	11498
2025 Q4	$209K	Buy	+2,087,404	New	+$1.33M	﹤0.01%	9636
2025 Q1	–	Sell	-51,049	Closed	-$43.7K	–	9364
2024 Q4	$43.7K	Sell	51,049 -32,711	-39%	-$205K	﹤0.01%	9002
2024 Q3	$712K	Sell	83,760 -26,066	-24%	-$154K	﹤0.01%	6570
2024 Q2	$513K	Sell	109,826 -134,786	-55%	-$638K	﹤0.01%	6986
2024 Q1	$1.66M	Buy	244,612 +112,706	+85%	+$506K	﹤0.01%	4466
2023 Q4	$442K	Sell	131,906 -71,273	-35%	-$177K	﹤0.01%	6976
2023 Q3	$506K	Buy	+203,179	New	+$335K	﹤0.01%	6286
2023 Q1	–	Sell	-17,707	Closed	-$13.5K	–	8967
2022 Q4	$13.5K	Buy	+17,707	New	+$14K	﹤0.01%	8696

Jane Street's APLT Position: Q1 2026 in Review

Jane Street sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 2,087,404 shares — an estimated $209K sold.

Jane Street first reported a position in APLT in Q4 2022 and held it in 8 quarters. The position peaked at $1.66M in Q1 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Jane Street reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Jane Street sold 2,087,404 Applied Therapeutics shares in Q1 2026, an estimated $209K.
Jane Street first reported a position in Applied Therapeutics in Q4 2022 and held it in 8 quarters.
Jane Street's Applied Therapeutics position peaked at $1.66M in Q1 2024.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.